Colleen K Correll

Colleen K Correll is an Associate Professor in Pediatric Rheumatology, Allergy & Immunology, affiliated with the University of Minnesota and actively collaborating with Duke University and the Childhood Arthritis & Rheumatology Research Alliance (CARRA). Her research is centered on improving outcomes for children with rheumatic diseases through epidemiological and clinical investigations.

Education:

• MD, Rush University
• BS, University of Illinois Chicago
• MPH, Epidemiology, University of Minnesota

Her research interests include pediatric rheumatology, systemic juvenile idiopathic arthritis (sJIA), childhood arthritis, pediatric lupus, spondyloarthritis, health disparities, pharmacokinetics of biologic drugs, medication adherence, and pediatric rheumatology workforce planning. She employs observational studies, registry data, and clinical trials to explore treatment effectiveness and health equity. Her recent publications (2024–2025) demonstrate a strong focus on real-world treatment outcomes, adherence interventions, and health services research in pediatric rheumatology.

Analysis of her recent articles reveals a consistent trend toward large-scale collaborative research using the CARRA Registry to address critical questions in treatment effectiveness, health disparities, and future healthcare needs in pediatric rheumatology. Her work bridges clinical care, epidemiology, and public health.

Scientific Awards:

• No awards listed in the provided text.

Dr. Correll is the Principal Investigator on multiple significant research grants, including the CARRA Registry Assistant Scientific Director position and studies on biomarkers in pediatric spondyloarthritis and pharmacokinetics in obese patients. These grants, funded by the NIH and other institutions, support her extensive research program. She is actively involved in mentoring and advising through her leadership roles, though specific students are not named. She leads and contributes to major collaborative research networks, particularly the CARRA Registry, which serves as a central platform for observational studies in pediatric rheumatic diseases.